Skip to NavigationSkip to content

News

Company issues statement after Smith comment
Study results cause switch from GSK's Avandia
But proposals draw criticism from all quarters
Product roundup in cancer, MS and diabetes
But NICE's cost restriction blocks combinination piill Inegy
Drug's lack of resistance problems and ease of administration makes its a promising contender in infection market
Company sets out on Crestor head-to-head against rival Vytorin
Deal reflects company's intention to invest in subcontinent and its overall global strategy
Drug expected to face tough competition in the anti-TNF market
Closure will result in loss of 420 jobs
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches